Trials / Completed
CompletedNCT01155882
Registry Study - Whipple at the Splenic Artery
Whipple at the Splenic Artery - A Procedure for Ductal Adenocarcinoma of the Pancreas With Extensive Involvement of the Porto-Mesenteric Axis: A Registry Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 13 (actual)
- Sponsor
- Washington University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine how effective Whipple at the Splenic Artery (WATSA).
Detailed description
Primary The primary objective of this registry study is to collect clinical data from patients who undergo the WATSA procedure. Specific hypotheses to be tested are * To determine how effective Whipple at the Splenic Artery (WATSA) is at resecting tumors with negative microscopic margins (R0) at the resection line on the pancreas and at the tangential posterior, uncinate, and venous margins. * To determine if WATSA can be performed within the usual range of morbidity and mortality (30 day postoperative mortality) for a standard a Whipple procedure. Secondary The secondary objectives of this registry study are to * To determine the survival/recurrence rates at 2 years. * To determine the effect of occlusion of the splenic vein at the confluence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Whipple at the Splenic Artery (WATSA) |
Timeline
- Start date
- 2010-09-20
- Primary completion
- 2019-01-16
- Completion
- 2019-01-16
- First posted
- 2010-07-02
- Last updated
- 2019-01-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01155882. Inclusion in this directory is not an endorsement.